ETST Earth Science Tech, Inc.
Listings ·
Shareholders approved authority for a reverse split tied to an uplisting, and a special committee to negotiate retiring the Series B preferred stock. The company's release reports no vote counts.
Earth Science Tech's board wants a non-binding stockholder signal on a reverse split to meet the bid price test for an uplisting. The company says it is not currently a listed issuer, and the proxy's notice gives no split ratio.
Earth Science Tech, Inc. is a diversified holding company headquartered in Miami, Florida, in the health and wellness sector. Its strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine, clinical support and patient fulfillment, along with real estate, asset management and a consumer products business. RxCompound, based in Miami, and Mister Meds, based in Abilene, Texas, are licensed compounding pharmacies that provide sterile and non-sterile medications. Peaks Curative offers asynchronous telemedicine consultations for compounded medications, and DOConsultation.com offers home-based therapies and virtual consultations. Las Villas Health Care is a brick-and-mortar facility, and Avenvi manages real estate, asset management and the company's share repurchase program. MagneChef, an 80%-owned direct-to-consumer brand, sells kitchen products built on proprietary intellectual property. The company says it has focused on non-dilutive financing since its final share issuance in October 2023, and that management holds approximately 48% of outstanding shares.
| Product or program | What it is | Stage |
|---|---|---|
| RxCompound | Miami-based licensed compounding pharmacy for sterile and non-sterile medications | |
| Mister Meds | Abilene, Texas compounding pharmacy with sterile compounding and hazardous drug handling | |
| Peaks Curative | Telemedicine referral platform for asynchronous consultations on compounded medications | |
| DOConsultation.com | Telehealth brand focused on home-based therapies and virtual consultations | |
| MagneChef | 80%-owned direct-to-consumer kitchen products brand using proprietary technology |
| Line | FY ended Mar 31, 2026 | FY ended Mar 31, 2025 |
|---|---|---|
| Net income (loss) | $3.6 million | $3.3 million |
| Cash from operations | $1.9 million | $4.4 million |
| Cash and equivalents | $796,797 | $1.5 million |
Our latest story on this, dated Sep 1, 2026: "Earth Science Tech holders approve reverse split authority for uplisting". The story links the filing or release it is based on. Read the story.
Earth Science Tech, Inc. trades under the ticker ETST on OTC.
Earth Science Tech, Inc. is listed on OTC.
The SEC Central Index Key (CIK) for Earth Science Tech, Inc. is 1538495. Its filings are on SEC EDGAR.
287,590,881 shares as of 2026-08-06, per the cover page of its 10-Q filed 2026-08-07.
Our directory records Earth Science Tech, Inc. under United States.
Our directory classifies Earth Science Tech, Inc. as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.
The ISIN recorded for Earth Science Tech, Inc. is US2703111037.
aibio.space lists Earth Science Tech, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
SEC records list its state or country of incorporation as FL.
Earth Science Tech, Inc. is a diversified holding company headquartered in Miami, Florida, in the health and wellness sector. Its strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine, clinical support and patient fulfillment, along with real estate, asset management and a consumer products business.
RxCompound: Miami-based licensed compounding pharmacy for sterile and non-sterile medications
Mister Meds: Abilene, Texas compounding pharmacy with sterile compounding and hazardous drug handling
Earth Science Tech, Inc. reported net income of $3.6 million for the fiscal year ended Mar 31, 2026, and generated $1.9 million of cash from operations, per its annual report to the SEC.
$631,118 in cash at Jun 30, 2026, per its 10-Q.
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07,7.01,9.01). Source
Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 2.01,7.01,9.01). Source
Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. Source
Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. Source
Reported a change of independent auditor. SEC Form 8-K (Items 4.01,7.01,9.01). Source
Reported a change of independent auditor. SEC Form 8-K (Items 2.01,4.01,9.01). Source
Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 2.01,9.01). Source
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio